Additionally, the inclusion of both subtypes in the overall cohort reflects the clinical reality faced at diagnosis while the OS and PFS findings indicate a correlation between the mixed group and GBM subgroup in relation to MGMT-methylation (significantly higher in both) suggesting that the observed increased survival may be driven by MGMT status rather than group composition. This evidence concerns the gene MGMT and glioblastoma.